Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jan 28, 2019; 25(4): 485-497
Published online Jan 28, 2019. doi: 10.3748/wjg.v25.i4.485
Table 1 Baseline clinical characteristics of patients with common bile duct stones
CharacteristicBefore matching
After matching
EST (n = 168)OCT (n = 134)P-valueEST (n = 88)OCT (n = 88)P-value
Age at enrollment, mean ± SD, yr57.1 ± 14.857.5 ± 13.50.79958.6 ± 14.758.4 ± 13.80.920
Sex, male/female, n73/9565/690.38138/5040/480.762
Bile duct diameter, mean ± SD, mm10.9 ± 4.414.4 ± 5.8< 0.001b12.4 ± 5.112.7 ± 4.20.663
Stone number, multiple/single, n63/10557/770.37433/5533/551.000
Maximum stone size, n (%)1.0 ± 0.51.4 ± 0.7< 0.001b1.2 ± 0.51.2 ± 0.60.484
Cholangitis on admission, n (%)42 (25.0)34 (25.4)0.94123 (26.1)22 (25.0)0.863
Mild28 (16.6)28 (20.9)0.13313 (14.7)18 (20.5)0.139
Moderate7 (4.2)5 (3.7)5 (5.7)3 (3.4)
Severe7 (4.2)1 (0.8)5 (5.7)1 (1.1)
Previous gastrectomy, n (%)
Billroth-I07 (5.2)0.006b---
Billroth-II09 (6.7)0.005b---
Hypertension, n (%)19 (11.3)15 (11.2)0.95112 (13.6)11 (12.5)0.823
Diabetes mellitus, n (%)11 (6.5)7 (5.2)0.6297 (7.9)6 (6.8)0.773
Charlson comorbidity index, mean ± SD0.7 ± 0.90.8 ± 1.00.3340.8 ± 1.00.8 ± 0.90.807
Prior cholecystectomy, n (%)18 (10.7)17 (12.7)0.59512 (13.6)9 (10.2)0.485
Gallbladder with stones in situ, n (%)150 (89.3)117 (87.3)0.59576 (86.4)79 (89.8)0.485
Preoperative biochemical parameters, median (IQR)
T-Bil, μmol/L18.9 (10.8-47.2)16.6 (9.5-39.1)0.16416.9 (10.3-43.5)15.4 (9.1-40.3)0.432
ALT, U/L81.5 (28.8-162.0)40.5 (18.0-96.3)< 0.001b56.0 (22.3-101.8)36.5 (17.5-98.3)0.264
AST, U/L47.0 (22.8-91.0)32.0 (20.0-62.2)0.05337.0 (21.8-79.3)29.0 (19.0-60.0)0.259
γ-GTP, U/L162.5 (82.0-266.3)147.0 (67.5-264.8)0.446131.5 (74.8-296.0)133.0 (64.8-226.8)0.380
ALP, U/L234.0 (76.0-475.5)126.5 (65.5-313.5)0.049a160.5 (66.3-351.5)121.0 (65.8-303.3)0.642
Follow up period, median (IQR), yr6.3 (5.4-7.3)6.2 (5.1-7.8)0.7326.3 (5.2-7.3)6.9 (5.4-8.2)0.168